MAb Order Form

Antibody Production
MAb Order Form
Axil Scientific Pte Ltd
41 Science Park Road, #01-22/23 The Gemini, Singapore Science Park II, Singapore 117610
T: +65 6775 7318 F: +65 6775 7211 E: [email protected]
First BASE Laboratories Sdn Bhd (604944-X)
Lot 7-1 to 7-3, Jalan SP 2/7, Taman Serdang Perdana, Seksyen 2, 43300 Seri Kembangan, Selangor, Malaysia
T: +603 8943 3252 F: +603 8943 3243 E: [email protected]
Date:
*Required Fields
CUSTOMER DETAILS
*Name:
Reference ID:
*Institute Name / Department
*Address:
*Contact Number:
(Office)
(Mobile)
*Email Address:
Principal Investigator / Supervisor:
Project Name/ID
MAb Packages and Services
Peptide Synthesized by ProSci
Peptide Name:
Sequence:
NH2-OH
Pkg. 1:
Pkg. 1S:
Pkg. 2:
Pkg. 2S:
Page 1 of 2
WB
WB
ICC
ICC
Peptide Synthesis (up to 35 residues)
Peptide HPLC purification >90%
Peptide Conjugation
Phase I – Immunization
Phase II – Fusion
Phase III – Sub-Cloning
Antigen Provided By Customer
Peptide
 3mg conjugated to a carrier protein
 4 mg free/unconjugated
Recombinant Protein
Researcher Screening of Positive Wells:
10 Positive Wells
No Charge
11-20 Positive Wells
No
Charge
21-40 Positive Wells
No
Charge
41-60 Positive Wells
No
Charge
61-80 Positive Wells
No
Charge
81-100 Positive Wells
No
Charge
Human / Animal Tissue
Chemicals / Drugs
Bacteria / Virus Extract
Immunogen Quantity
Immunogen MW
Immunogen Purity (≥90%)
Immunogen Buffer
Immunogen Concentration
ProSci Screening of Positive Wells:
ProSci-Provided Lysate WB Screening
Client-Provided Lysate WB Screening
ProSci Immunocytochemistry Screening
ProSci WB and ICC Screening
Buffer pH
Preservative
Amount
Other Chemical
Amount
Fusion Partner Yes
No
Carrier Protein
Carrier MW
If using ProSci-Provided Screening options, please
specify:
ProSci Lysate (WB):
ProSci Cell Line (ICC):
Additional Clones
1-3 Clones
4-6 Clones
7-10 Clones
Additional Services:
Dual ELISA Screening
Clone Isotyping
Additional Instructions:
120604
I acknowledge that I have read, understand, and agree to ProSci Incorporated’s Terms and Conditions for
Hybridoma Development.
Signature: _______________
Printed Name:
Date:
Page 2 of 2